BSX earnings date and last-quarter result: next report 2026-07-29, last quarter beat, P/E 17.90. Updated 2026-07-23.
Boston Scientific (BSX) Research Hub
Boston Scientific (BSX) trades on NYSE, US in the Healthcare (Medical - Devices) sector. As of 2026-10-26, shares last closed at 45.58 USD (-0.24%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 17.90, market cap 63.73B. This hub links to the full technical, earnings and options research available for BSX.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NYSE, US |
| Last close | 45.58 USD (-0.24%) |
| 52-week range | 41.39 USD – 52.56 USD |
| Trend regime | Range |
| 14-day RSI | 68.2 (Bullish) |
| Trailing P/E | 17.90 |
| Market cap | 63.73B |
| Dividend yield | 0.00% |
| Next earnings | 2026-07-29 |
Available research for BSX
Covered Call on BSX: how it works, illustrative setup around the real 45.58 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on BSX: how it works, illustrative setup around the real 45.58 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on BSX: how it works, illustrative setup around the real 45.58 USD price, max profit/loss, breakeven and when to use it. Educational.
BSX technical analysis: range, last 45.58 USD, RSI 68.2, 52w range 41.39 USD–52.56 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is BSX in?
Boston Scientific (BSX) is classified under Healthcare (Medical - Devices), listed on NYSE, US.
Is BSX in an uptrend or downtrend?
As of 2026-10-26, BSX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is BSX's trailing P/E ratio?
BSX's trailing P/E is 17.90, with a market cap of 63.73B. See the earnings research page for full valuation detail.
When does BSX next report earnings?
BSX is next scheduled to report earnings on 2026-07-29.